title: Serenics.
authors.affiliation: CNS-Research, Drug Discovery Section, Solvay Duphar b.v., Weesp, The Netherlands.
authors.forename: B
authors.initials: B
authors.lastname: Olivier
authors.forename: J
authors.initials: J
authors.lastname: Mos
authors.forename: M
authors.initials: M
authors.lastname: Raghoebar
authors.forename: P
authors.initials: P
authors.lastname: de Koning
authors.forename: M
authors.initials: M
authors.lastname: Mak
mesh_terms: D000374:Aggression / Q000187:drug effects*; D000818:Animals; D003674:Defense Mechanisms; D004193:Discrimination Learning / Q000187:drug effects; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects; D010879:Piperazines / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000494:pharmacology*; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*; D013329:Structure-Activity Relationship
chemical_list: D010879:Piperazines; D011619:Psychotropic Drugs; D017366:Serotonin Receptor Agonists; C063828:eltoprazine